Nurtec ODT 75 MG tablet 8S
Ended Awarded
- Contract number
- SPE2DB26FATYV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,621
Award facts
- Contract value 100% obligated
- $6,621.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,621.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 8-count tablets of NURTEC ODT 75 mg, a migraine treatment medication. The delivery order, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, carries no set-aside designation and will be performed in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the sole awardee with no identified subcontractors on this engagement.
This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense military healthcare facilities worldwide. The underlying IDC, awarded in November 2025 with a $499,999,999 ceiling and completion date of December 31, 2036, authorizes the company to supply branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support recurring medical supply needs across the federal military medical system. DMS Pharmaceutical Group's established performance across numerous recent delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FATYV?
SPE2DB26FATYV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FATYV worth?
The government has obligated $6,621 on SPE2DB26FATYV.
Is contract SPE2DB26FATYV an order under another contract?
Yes. SPE2DB26FATYV is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATYV competed?
The extent of competition for SPE2DB26FATYV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award